In conclusion, triphasic enhanced CT radiomics models were constructed to predict KRAS mutation status in colorectal cancer, and the results showed that the AP, VP, and DP models could better predict KRAS mutation status in the training and validation cohorts. Here, KRAS is linked to colorectal cancer.